Related references
Note: Only part of the references are listed.Down syndrome and the complexity of genome dosage imbalance
Stylianos E. Antonarakis
NATURE REVIEWS GENETICS (2017)
Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling
Daniel C. Berwick et al.
MOLECULAR NEURODEGENERATION (2017)
The Dkk3 gene encodes a vital intracellular regulator of cell proliferation
Jack L. Leonard et al.
PLOS ONE (2017)
Subcellular distribution of cyclin-dependent kinase-like 5 (CDKL5) is regulated through phosphorylation by dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A)
Ami Oi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapies
Ke Yang et al.
LABORATORY INVESTIGATION (2016)
Wnt/β-catenin signaling in melanoma: Preclinical rationale and novel therapeutic insights
Gongda Xue et al.
CANCER TREATMENT REVIEWS (2016)
Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination
Jose Luis Olmos-Serrano et al.
NEURON (2016)
Genetic dissection of Down syndrome-associated congenital heart defects using a new mouse mapping panel
Eva Lana-Elola et al.
ELIFE (2016)
Trisomy 21 consistently activates the interferon response
Kelly D. Sullivan et al.
ELIFE (2016)
Protective LRRK2 R1398H Variant Enhances GTPase and Wnt Signaling Activity
Jonathon Nixon-Abell et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2016)
Alzheimer Disease: Crosstalk between the Canonical Wnt/Beta-Catenin Pathway and PPARs Alpha and Gamma
Alexandre Vallee et al.
FRONTIERS IN NEUROSCIENCE (2016)
Treadmill exercise ameliorates Alzheimer disease-associated memory loss through the Wnt signaling pathway in the streptozotocin-induced diabetic rats
Dae-Young Kim et al.
JOURNAL OF EXERCISE REHABILITATION (2016)
Ethosuximide Induces Hippocampal Neurogenesis and Reverses Cognitive Deficits in an Amyloid-β Toxin-induced Alzheimer Rat Model via the Phosphatidylinositol 3-Kinase (PI3K)/Akt/Wnt/β-Catenin Pathway
Shashi Kant Tiwari et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
A novel DYRK1A (Dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro
Severine Coutadeur et al.
JOURNAL OF NEUROCHEMISTRY (2015)
A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome
Frances K. Wiseman et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Inhibition of DYRK1A and GSK3B induces human β-cell proliferation
Weijun Shen et al.
NATURE COMMUNICATIONS (2015)
Dissecting Alzheimer disease in Down syndrome using mouse models
Xun Yu Choong et al.
Frontiers in Behavioral Neuroscience (2015)
DYRK1A-mediated Cyclin D1 Degradation in Neural Stem Cells Contributes to the Neurogenic Cortical Defects in Down Syndrome
Sonia Najas et al.
EBIOMEDICINE (2015)
Wnt signalling in neuronal differentiation and development
Nibaldo C. Inestrosa et al.
CELL AND TISSUE RESEARCH (2015)
Phosphorylation and Inactivation of Glycogen Synthase Kinase 3β (GSK3β) by Dual-specificity Tyrosine Phosphorylation-regulated Kinase 1A (Dyrk1A)
Woo-Joo Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
STRING v10: protein-protein interaction networks, integrated over the tree of life
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2015)
DYRK1A Controls HIV-1 Replication at a Transcriptional Level in an NFAT Dependent Manner
Thijs Booiman et al.
PLOS ONE (2015)
Causal analysis approaches in Ingenuity Pathway Analysis
Andreas Kraemer et al.
BIOINFORMATICS (2014)
Research Highlights Wnt-Signalling: A New Direction for Alzheimer Disease?
Stephen D. Skaper
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2014)
DYRK1A: A Potential Drug Target for Multiple Down Syndrome Neuropathologies
Walter Becker et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2014)
Clinical Practice Guidelines for Management of Children With Down Syndrome: Part I
Daniel L. Ivan et al.
JOURNAL OF PEDIATRIC HEALTH CARE (2014)
Wnt Signaling Pathway in Non-Small Cell Lung Cancer
David J. Stewart
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans
Rafael De la Torre et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2014)
Domains of genome-wide gene expression dysregulation in Down's syndrome
Audrey Letourneau et al.
NATURE (2014)
Regulating Wnt signaling: a strategy to prevent neurodegeneration and induce regeneration
Kirsten Harvey et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2014)
Dysfunction of Wnt signaling and synaptic disassembly in neurodegenerative diseases
Silvia A. Purro et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2014)
The Role of Wnt Signaling in the Development of Alzheimer's Disease: A Potential Therapeutic Target?
Wenbin Wan et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Plasma DYRK1A as a novel risk factor for Alzheimer's disease
N. Janel et al.
TRANSLATIONAL PSYCHIATRY (2014)
Hepatocyte-specific Dyrk1a gene transfer rescues plasma apolipoprotein A-I levels and aortic Akt/GSK3 pathways in hyperhomocysteinemic mice
Asma Tlili et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Loss of Dickkopf-1 Restores Neurogenesis in Old Age and Counteracts Cognitive Decline
Desiree R. M. Seib et al.
CELL STEM CELL (2013)
Protein profiles in Tc1 mice implicate novel pathway perturbations in the Down syndrome brain
Md. Mahiuddin Ahmed et al.
HUMAN MOLECULAR GENETICS (2013)
Lithium rescues synaptic plasticity and memory in Down syndrome mice
Andrea Contestabile et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Massively Parallel Sequencing Reveals the Complex Structure of an Irradiated Human Chromosome on a Mouse Background in the Tc1 Model of Down Syndrome
Susan M. Gribble et al.
PLOS ONE (2013)
WNT signalling pathways as therapeutic targets in cancer
Jamie N. Anastas et al.
NATURE REVIEWS CANCER (2013)
Wnt signalling and its role in stem cell-driven intestinal regeneration and hyperplasia
J. B. Cordero et al.
ACTA PHYSIOLOGICA (2012)
The APP intracellular domain (AICD) inhibits Wnt signalling and promotes neurite outgrowth
Fangfang Zhou et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
Three decades of Wnts: a personal perspective on how a scientific field developed
Roel Nusse et al.
EMBO JOURNAL (2012)
Down's-syndrome-related kinase Dyrk1A modulates the p120-catenin-Kaiso trajectory of the Wnt signaling pathway
Ji Yeon Hong et al.
JOURNAL OF CELL SCIENCE (2012)
Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome
Sebastien Malinge et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Wnt Signaling: Role in Alzheimer Disease and Schizophrenia
Nibaldo C. Inestrosa et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
The Secreted Wnt Antagonist Dickkopf-1 Is Required for Amyloid β-Mediated Synaptic Loss
Silvia A. Purro et al.
JOURNAL OF NEUROSCIENCE (2012)
Altered regulation of tau phosphorylation in a mouse model of down syndrome aging
Olivia Sheppard et al.
NEUROBIOLOGY OF AGING (2012)
Prenatal diagnosis of Down syndrome: a systematic review of termination rates (1995-2011)
Jaime L. Natoli et al.
PRENATAL DIAGNOSIS (2012)
Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A)
Tatyana Adayev et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2011)
Transient expression of Mnb/Dyrk1a couples cell cycle exit and differentiation of neuronal precursors by inducing p27KIP1 expression and suppressing NOTCH signaling
Barbara Haemmerle et al.
DEVELOPMENT (2011)
Recent insights into the function of DYRK1A
Walter Becker
FEBS JOURNAL (2011)
Link Between DYRK1A Overexpression and Several-Fold Enhancement of Neurofibrillary Degeneration With 3-Repeat Tau Protein in Down Syndrome
Jerzy Wegiel et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions
Tao Yu et al.
HUMAN MOLECULAR GENETICS (2010)
Dyrk1A-mediated phosphorylation of Presenilin 1: a functional link between Down syndrome and Alzheimer's disease
Young Shin Ryu et al.
JOURNAL OF NEUROCHEMISTRY (2010)
DYRK1A and Glycogen Synthase Kinase 3β, a Dual-Kinase Mechanism Directing Proteasomal Degradation of CRY2 for Circadian Timekeeping
Nobuhiro Kurabayashi et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Wnt signaling activation reduces neuropathological markers in a mouse model of Alzheimer's disease
E M Toledo et al.
MOLECULAR PSYCHIATRY (2010)
When pathways collide: collaboration and connivance among signalling proteins in development
Helen McNeill et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Emerging roles of Wnts in the adult nervous system
Nibaldo C. Inestrosa et al.
NATURE REVIEWS NEUROSCIENCE (2010)
Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A
Yasushi Ogawa et al.
NATURE COMMUNICATIONS (2010)
Function and regulation of Dyrk1A: towards understanding Down syndrome
Joongkyu Park et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Mutations in the LRRK2 Roc-COR tandem domain link Parkinson's disease to Wnt signalling pathways
Rosa M. Sancho et al.
HUMAN MOLECULAR GENETICS (2009)
Nonprimed and DYRK1A-primed GSK3β-phosphorylation sites on MAP1B regulate microtubule dynamics in growing axons
Timothy M. E. Scales et al.
JOURNAL OF CELL SCIENCE (2009)
Attenuation of Notch signalling by the Down-syndrome-associated kinase DYRK1A
Javier Fernandez-Martinez et al.
JOURNAL OF CELL SCIENCE (2009)
Dkk-3 is elevated in CSF and plasma of Alzheimer's disease patients
Christoph Zenzmaier et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Wnt signalling in development and disease - Max Delbruck center for molecular medicine meeting on Wnt signaling in development and disease
Christophe Fuerer et al.
EMBO REPORTS (2008)
The spatio-temporal and subcellular expression of the candidate Down syndrome gene Mnb/Dyrk1A in the developing mouse brain suggests distinct sequential roles in neuronal development
Barbara Hammerle et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Mental retardation and associated neurological dysfunctions in Down syndrome: A consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways
Mohammed Rachidi et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2008)
Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of tau in Down syndrome
Jianhua Shi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease
Soo-Ryoon Ryoo et al.
JOURNAL OF NEUROCHEMISTRY (2008)
DYRK1A-mediated hyperphosphorylation of Tau - A functional link between Down syndrome and Alzheimer disease
Soo-Ryoon Ryoo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Dyrk1A overexpression in immortalized hippocampal cells produces the neuropathological features of Down syndrome
Joongkyu Park et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2007)
Inhibition of glycogen synthase kinase-3 suppresses the onset of symptoms and disease progression of G93A-SOD1 mouse model of ALS
Seong-Ho Koh et al.
EXPERIMENTAL NEUROLOGY (2007)
The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease
Ryo Kimura et al.
HUMAN MOLECULAR GENETICS (2007)
Epidemiology of Down syndrome
Stephanie L. Sherman et al.
MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS (2007)
The profile and incidence of cancer in Down syndrome
S. G. Sullivan et al.
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2007)
Dishevelled: a protein that functions in living cells by phase separating
Richard P. Sear
SOFT MATTER (2007)
NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21
Joseph R. Arron et al.
NATURE (2006)
Gene-dosage effect on chromosome 21 transcriptome in trisomy 21: Implication in Down syndrome cognitive disorders
Pascal Kahlem
BEHAVIOR GENETICS (2006)
Activity-dependent synaptic Wnt release regulates hippocampal long term potentiation
JY Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The Rac activator Tiam1 is a Wnt-responsive gene that modifies intestinal tumor development
A Malliri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The Wnt signalling effector Dishevelled form dynamic protein assemblies rather than stabile associations with cytoplasmic vesicles
T Schwarz-Romond et al.
JOURNAL OF CELL SCIENCE (2005)
Wnt signalling regulates adult hippocampal neurogenesis
DC Lie et al.
NATURE (2005)
An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes
A O'Doherty et al.
SCIENCE (2005)
Wnt signalling in stem cells and cancer
T Reya et al.
NATURE (2005)
Characterisation of the Wnt antagonists and their response to conditionally activated Wnt signalling in the developing mouse forebrain
DB Diep et al.
DEVELOPMENTAL BRAIN RESEARCH (2004)
Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain
A Caricasole et al.
JOURNAL OF NEUROSCIENCE (2004)
DYRK1A accumulates in splicing speckles through a novel targeting signal and induces speckle disassembly
M Alvarez et al.
JOURNAL OF CELL SCIENCE (2003)
Expression patterns and subcellular localization of the Down syndrome candidate protein MNB/DYRK1A suggest a role in late neuronal differentiation
B Hämmerle et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements
MT Veeman et al.
CURRENT BIOLOGY (2003)
The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bε at Ser539 and the microtubule-associated protein tau at Thr212:: potential role for DYRK as a glycogen synthase kinase 3-priming kinase
YL Woods et al.
BIOCHEMICAL JOURNAL (2001)
The protein-protein interaction map of Helicobacter pylori
JC Rain et al.
NATURE (2001)
Share Paper
